Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

ClinicalTrials.gov ID: NCT06373731

Public ClinicalTrials.gov record NCT06373731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ReNEW: A Phase 3, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects Who Have Dry Age-Related Macular Degeneration (Dry AMD)

Study identification

NCT ID
NCT06373731
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Stealth BioTherapeutics Inc.
Industry
Enrollment
313 participants

Conditions and interventions

Interventions

  • Elamipretide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 29, 2024
Primary completion
Jul 31, 2027
Completion
Aug 31, 2027
Last update posted
May 19, 2026

2024 – 2027

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Associated Retina Consultants Phoenix Arizona 85020
Barnet Dulaney Perkins Eye Center Sun City Arizona 85351
Retina Associates of Southern California Huntington Beach California 92607
Retina Consultants of San Diego Poway California 92064
Retinal Consultants Medical Group Sacramento California 95825
Orange County Retinal Medical Group Santa Ana California 92705
Bay Area Retina Associates Walnut Creek California 94598
Retina Consultants of Southern Colorado Colorado Springs Colorado 80909
Connecticut Eye Consultants, P.C. Danbury Connecticut 06810
Vitreo Retinal Associates Gainesville Florida 32607
Florida Retina Institute Orlando Florida 32806
Retina Vitreous Associates of Florida St. Petersburg Florida 33711
University Retina and Macula Associates Oak Forest Illinois 60452
Associated Vitreoretinal and Uveitis Consultants Carmel Indiana 46290
Mid Atlantic Retina Specialist Hagerstown Maryland 21740
Ophthalmic Consultants of Boston Boston Massachusetts 02114
Kellogg Eye Center Ann Arbor Michigan 48105
Retina Consultants of Minnesota Minneapolis Minnesota 55435
Mid Atlantic Retina Cherry Hill New Jersey 08034
NJ Retina Teaneck New Jersey 07666
Retina Vitreous Center Edmond Oklahoma 73013
Retina Northwest, PC Portland Oregon 97221
Retina Research Institute of Texas Abilene Texas 79606
Austin Clinical Research, LLC Austin Texas 78750
Retina Consultants of Texas Bellaire Texas 77401
Valley Retina Institute McAllen Texas 78503
Texas Retina Associates of Plano Plano Texas 75075
Medical Center Ophthalmology Associates San Antonio Texas 78240
Retina Consultants of Texas The Woodlands Texas 77384
Emerson Clinical Research Institute Falls Church Virginia 22042
Pacific Northwest Retina, PLLC Silverdale Washington 98383

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06373731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06373731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →